Kairos Pharma, Ltd. KAPA

1.72 (0.05) (2.82%) as of 25 Sep

Follow KAPA

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(113.96%)	(93.84%)	(97.99%)	(92.07%)	+8 more TTM periods Free account
ROA Full definition →	(104.32%)	(85.36%)	(88.51%)	(77.46%)
ROIC Full definition →	(322.91%)	(369.94%)	(346.52%)	(339.63%)
Return on Tangible Assets Full definition →	(199.55%)	(145.54%)	(104.99%)	(80.94%)
Free Cash Flow per Share Full definition →	(1.30)	(1.25)	(1.31)	(1.44)
Free Cash Flow Full definition →	(3.97)	(3.76)	(3.44)	(4.16)
Piotroski F-Score Full definition →	3.00	3.00	3.00	2.00
Other line items
Cash ROIC Full definition →	(54.92%)	(39.14%)	(29.47%)	(29.10%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.68	0.64	0.63	0.82
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(1.30)	(1.25)	(1.31)	(1.44)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack